Brazil vs India: Number of new G2D leprosy cases
Brazil
2,236
in 2024
India
1,888
in 2024
Brazil rank
1st
India rank
2nd
Number of new G2D leprosy cases over time
- Brazil
- India
How they compare
Brazil currently reports 2,236 against 1,888 in India, a difference of 348.
That makes Brazil's figure about 1.2 times India's.
The two have swapped places 1 time across 13 shared years of data; in 2012 it was India ahead.
Brazil ranks 1st and India ranks 2nd of 161 countries.
India has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brazil | India | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2,036 | 4,722 | 2,686 | India |
| 2020s | 1,913 | 2,004 | 90.8 | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of new g2d leprosy cases, Brazil or India?
- Brazil, at 2,236 against 1,888 in India as of 2024.
- What is the difference in number of new g2d leprosy cases between Brazil and India?
- 348, with Brazil ahead.
- How many years of comparable data are there for Brazil and India?
- 13 years are reported by both, from 2012 to 2024.
- How do Brazil and India rank globally for number of new g2d leprosy cases?
- Brazil ranks 1st and India ranks 2nd of 161 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of new G2D leprosy cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.